Special Drug Use-results Surveillance of Tabrecta Tablets
Special Drug Use-results Surveillance of Tabrecta Tablets (MET Exon 14 Skipping Mutation-positive Unresectable Advanced/Recurrent Non-small Cell Lung Cancer)
ClinicalTrials.gov Identifier: NCT04575025
Novartis Reference Number: CINC280AJP01
Last Update: Nov 25, 2022
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the use(s) under investigation.
Study Description
This study is an uncontrolled, primary data collection-based observational study to be conducted as a central registration system, multicenter special drug-use results surveillance. As an all-case study, this study will collect all patients treated with Tabrecta in a specified post-marketing period. The observation period of each patient is up to 1 year (52 weeks)
Condition
Non-small Cell Lung Cancer
Phase
Not Given
Overall status
Recruiting
Start date
Nov 02, 2020
Completion date
Mar 31, 2025
Gender
All
Age(s)
99 Years and older (Child, Adult, Older Adult)
Interventions
Drug
Tabrecta tablets
There is no treatment allocation. Patients administered Tabrecta by prescription that have started before inclusion of the patient into the study will be enrolled.
Eligibility Criteria
Inclusion Criteria:
All patients receiving Tabrecta for MET exon 14 skipping mutation-positive unresectable advanced/recurrent NSCLC during a specified post-marketing period
Exclusion Criteria:
-
Study Locations
Japan
Novartis Investigative Site
Recruiting
Nagoya, 457-0818
Aichi
Japan
Novartis Investigative Site
Recruiting
Nagoya, 462-0057
Aichi
Japan
Novartis Investigative Site
Recruiting
Nagoya, 464 8681
Aichi
Japan
Novartis Investigative Site
Recruiting
Okazaki-city, 444-8553
Aichi
Japan
Novartis Investigative Site
Recruiting
Toyoake city, 470 1192
Aichi
Japan
Novartis Investigative Site
Recruiting
Toyota, 470-0343
Aichi
Japan
Novartis Investigative Site
Recruiting
Daisen, 014-0027
Akita
Japan
Novartis Investigative Site
Recruiting
Sakura, 285-8741
Chiba
Japan
Novartis Investigative Site
Recruiting
Yoshida-gun, 910-1193
Fukui
Japan
Novartis Investigative Site
Recruiting
Fukuoka city, 812-8582
Fukuoka
Japan
Novartis Investigative Site
Recruiting
Fukuoka city, 814 0180
Fukuoka
Japan
Novartis Investigative Site
Recruiting
Iizuka, 820-0076
Fukuoka
Japan
Novartis Investigative Site
Recruiting
Kitakyushu-city, 806-8501
Fukuoka
Japan
Novartis Investigative Site
Recruiting
Fukushima city, 960 1295
Fukushima
Japan
Novartis Investigative Site
Recruiting
Higashihiroshima, 739-0041
Hiroshima
Japan
Novartis Investigative Site
Recruiting
Hiroshima-city, 734-8530
Hiroshima
Japan
Novartis Investigative Site
Recruiting
Akashi, 673-8558
Hyogo
Japan
Novartis Investigative Site
Recruiting
Himeji, 670-8520
Hyogo
Japan
Novartis Investigative Site
Recruiting
Nishinomiya, 663 8501
Hyogo
Japan
Novartis Investigative Site
Recruiting
Tsuchiura, 300-0028
Ibaraki
Japan
Novartis Investigative Site
Recruiting
Tsukuba, 305-8558
Ibaraki
Japan
Novartis Investigative Site
Recruiting
Takamatsu-city, 760-0017
Kagawa
Japan
Novartis Investigative Site
Recruiting
Fujisawa, 251-8550
Kanagawa
Japan
Novartis Investigative Site
Recruiting
Yokohama-city, 241-8515
Kanagawa
Japan
Novartis Investigative Site
Recruiting
Yokohama, 220-8521
Kanagawa
Japan
Novartis Investigative Site
Recruiting
Yokohama, 221-0855
Kanagawa
Japan
Novartis Investigative Site
Recruiting
Yokohama, 234-0054
Kanagawa
Japan
Novartis Investigative Site
Recruiting
Kumamoto City, 860-8556
Kumamoto
Japan
Novartis Investigative Site
Recruiting
Tsu-city, 514-8507
Mie
Japan
Novartis Investigative Site
Recruiting
Matsumoto-city, 390-8621
Nagano
Japan
Novartis Investigative Site
Recruiting
Nagasaki-city, 852-8501
Nagasaki
Japan
Novartis Investigative Site
Recruiting
Kurashiki, 701-0192
Okayama
Japan
Novartis Investigative Site
Recruiting
Okayama-city, 700-8558
Okayama
Japan
Novartis Investigative Site
Recruiting
Kishiwada-city, 596-8501
Osaka
Japan
Novartis Investigative Site
Recruiting
Osaka-city, 540-0006
Osaka
Japan
Novartis Investigative Site
Recruiting
Osaka-city, 541-8567
Osaka
Japan
Novartis Investigative Site
Recruiting
Osaka-city, 543-8555
Osaka
Japan
Novartis Investigative Site
Recruiting
Saga-city, 849-8501
Saga
Japan
Novartis Investigative Site
Recruiting
Kawaguchi, 332-8558
Saitama
Japan
Novartis Investigative Site
Recruiting
Kumagaya, 360-0197
Saitama
Japan
Novartis Investigative Site
Recruiting
Sunto Gun, 411 8777
Shizuoka
Japan
Novartis Investigative Site
Recruiting
Shimotsuga Gun, 321-0293
Tochigi
Japan
Novartis Investigative Site
Recruiting
Chuo ku, 104 0045
Tokyo
Japan
Novartis Investigative Site
Recruiting
Koto ku, 135 8550
Tokyo
Japan
Novartis Investigative Site
Recruiting
Minato-ku, 105-8471
Tokyo
Japan
Novartis Investigative Site
Recruiting
Shibuya, 150-8935
Tokyo
Japan
Novartis Investigative Site
Recruiting
Shinjuku-ku, 160-0023
Tokyo
Japan
Novartis Investigative Site
Recruiting
Toyama-city, 930-0194
Toyama
Japan
Novartis Investigative Site
Recruiting
Higashi-okitama, 992-0601
Yamagata
Japan
Novartis Investigative Site
Recruiting
Chiba, 261-0001
-
Japan
Novartis Investigative Site
Recruiting
Fukui, 918-8501
-
Japan
Novartis Investigative Site
Recruiting
Saitama, 330 8503
-
Japan
Novartis Investigative Site
Recruiting
Saitama, 330-8553
-
Japan
Contacts
Have a question?
Call 1-888-669-6682 or email [email protected]